Skip to main content
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · IEX Real-Time Price · USD
5.03
-0.09 (-1.76%)
Apr 17, 2024, 3:03 PM EDT - Market closed

Champions Oncology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Champions Oncology stock has a target of 7.50, which predicts an increase of 49.11% from the current stock price of 5.03.

Analyst Consensus: Buy
Target Low Average Median High
Price $7.50 $7.50 $7.50 $7.50
Change +49.11% +49.11% +49.11% +49.11%
* Price targets were last updated on Sep 22, 2023.

Analyst Ratings

The average analyst rating for CSBR stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Feb '24Mar '24Apr '24
Strong Buy 111
Buy 000
Hold 011
Sell 000
Strong Sell 000
Total 122

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Matt Hewitt
Craig-Hallum
 Craig-Hallum
Hold
Downgrades
n/a
 Hold Downgrades n/a n/a Mar 13, 2024
Scott Henry
Roth MKM
 Roth MKM
Strong Buy
Maintains
$9 → $7.5
 Strong Buy Maintains $9 → $7.5 +49.11% Sep 22, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
49.82M
from 53.87M
Decreased by -7.51%
Revenue Next Year
54.75M
from 49.82M
Increased by 9.89%
EPS This Year
-0.64
from -0.39
EPS Next Year
-0.35
from -0.64
Year 20192020202120222023202420252026202720282029
Revenue
27.07M32.12M41.04M49.11M53.87M49.82M54.75M70.99M81.64M95.93M113.19M
Revenue Growth
33.72%18.68%27.76%19.66%9.69%-7.51%9.89%29.66%15.00%17.50%18.00%
EPS
0.01-0.180.020.04-0.39-0.64-0.35----
EPS Growth
---100.00%-------
No. Analysts -----333333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 51.3M 56.4M 73.1M 84.0M 98.7M 116.5M
Avg 49.8M 54.7M 71.0M 81.6M 95.9M 113.2M
Low 47.9M 52.6M 68.2M 78.4M 92.2M 108.8M

Revenue Growth

Revenue Growth 202420252026202720282029
High
-4.8%
13.1%
33.5%
18.4%
21.0%
21.5%
Avg
-7.5%
9.9%
29.7%
15.0%
17.5%
18.0%
Low
-11.1%
5.6%
24.6%
10.5%
12.9%
13.4%

EPS Forecast

EPS 20242025
High -0.66 -0.36
Avg -0.64 -0.35
Low -0.62 -0.33

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.